Lenvanib 4mg Capsule

About

Lenvanib 4mg Capsule is a multi-kinase inhibitor that targets several receptor tyrosine kinases (RTKs) and other pro-angiogenic and oncogenic signaling pathways. It inhibits vascular endothelial growth factor receptors (VEGFR1, VEGFR2, VEGFR3), fibroblast growth factor receptors (FGFR1, FGFR2, FGFR3, FGFR4), platelet-derived growth factor receptor alpha (PDGFRα), KIT, and RET. This broad spectrum of inhibition disrupts tumor angiogenesis, tumor growth, and other processes critical for cancer progression. Lenvanib is used in the treatment of various advanced cancers, offering a targeted approach to inhibit multiple pathways simultaneously, thereby improving patient outcomes in challenging malignancies.

Uses

• Treatment of differentiated thyroid cancer (DTC).
• Management of advanced renal cell carcinoma (RCC).
• Treatment of hepatocellular carcinoma (HCC).
• Used in combination for advanced endometrial carcinoma.

Directions For Use

Take Lenvanib 4mg Capsule orally once daily, with or without food, at the same time each day. Swallow the capsule whole.

Benefits

• Targets multiple cancer-driving kinases.
• Inhibits tumor angiogenesis and growth.
• Effective in various advanced cancers.
• Oral, once-daily administration.
• May improve progression-free survival.
• Offers a targeted therapy option.

Side Effects

• Hypertension
• Fatigue
• Diarrhea
• Arthralgia/myalgia
• Decreased appetite
• Nausea
• Vomiting
• Weight loss
• Proteinuria
• Hand-foot syndrome
• Headache
• Hypothyroidism

Safety Measures

• Alcohol - Avoid or limit alcohol consumption as it may exacerbate certain side effects like fatigue or gastrointestinal issues.
• Pregnancy - Lenvanib is contraindicated in pregnancy due to potential for fetal harm. Effective contraception is required during treatment and for a period after.
• Breastfeeding - Breastfeeding is not recommended during Lenvanib treatment and for a specified period after the last dose, due to potential harm to the infant.
• Liver - Use with caution in patients with hepatic impairment; dose adjustments are often necessary. Monitor liver function closely.
• Kidney - Use with caution in patients with renal impairment; dose adjustments may be required based on the severity of kidney dysfunction.
• Lung - Monitor for new or worsening pulmonary symptoms, as interstitial lung disease or pneumonitis can occur rarely.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.